As of 28 Aug 2026, Alembic Pharmaceuticals Ltd share price is ₹823.50. The stock opened at ₹823.50 and had closed at ₹823.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹635.30 and a high of ₹998.00. In terms of performance, Alembic Pharmaceuticals Ltd share price has increased by 11.52% over the past six months and has decreased by 12.12% over the last year.
APLLTD Charts
Alembic Pharmaceuticals Ltd Overview
About APLLTD
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
Alembic Pharmaceuticals Ltd Historical Performance
Alembic Pharmaceuticals Ltd Fundamental Analysis
Alembic Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 1,882.10 | 1,744.62 | 1,652.97 | 1,807.73 | 1,501.96 |
| EBITDA | 359.86 | 275.19 | 240.10 | 314.80 | 221.53 |
| Net Profit | 196.96 | 243.07 | 114.47 | 179.36 | 103.52 |
| EPS | 10.02 | 12.37 | 5.82 | 9.12 | 5.27 |
Alembic Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 52.69 |
| MACD | 1.36 |
| 20-Day SMA | 820.49 |
Alembic Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Alembic Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Alembic Pharmaceuticals Ltd today is ₹823.50 on NSE and ₹823.50 on BSE.
- The 52-week high of Alembic Pharmaceuticals Ltd is ₹998.00, while the 52-week low is ₹635.30.
- The current market capitalisation of Alembic Pharmaceuticals Ltd is approximately ₹16,194 crore.
- The P/E (Price-to-Earnings) ratio of Alembic Pharmaceuticals Ltd is 21.92. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Alembic Pharmaceuticals Ltd is 2.58. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Alembic Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Alembic Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Alembic Pharmaceuticals Ltd has delivered a return of approximately 9.82%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Alembic Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 69.87% promoters, -4.56% FIIs, 15.94% DIIs, and 6.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
